Attached files
file | filename |
---|---|
10-K/A - AMENDED 10K - Vansen Pharma Inc. | okanaform10kafinal.htm |
EX-31 - CERTIFICATION - Vansen Pharma Inc. | exhibit3110ka123109.htm |
Exhibit 32
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
In connection with the amended Annual Report of Okana Ventures, Inc., a Nevada corporation (the Company), on Form 10-K/A for the year ending December 31, 2009, as filed with the Securities and Exchange Commission (the Report), I, Michael Upham, President/Secretary/Treasurer/CEO/CFO of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Michael Upham
Michael Upham
President, Secretary, Treasurer, CEO, CFO
Dated: March 9, 2010